Skip to content
Events

Details

Innovation in genomics means we now have access to more of the information locked in our DNA. As this information becomes routinely used to manage our health, lifestyle and prevent disease, we must ensure equitable access to these new technologies for underrepresented communities.

Exciting advances have occurred in our understanding of the gut microbiome, our biological age via epigenetics and how genetic variants predispose us to disease. Together these advances unlock new potential for greater wellness and healthier lives. Learn how global innovators such as Microba, CeraScreen, Allelica and 54gene are making this a reality.

Our next event in the Consumer & Healthcare Genomics Virtual Summit will introduce direct-to-consumer genomics companies that are making significant advances in a range of exciting areas such as the use of polygenic risk scores for disease prevention, epigenetics to determine biological age and microbiome for gut health.

By showcasing emerging and innovative applications in genomics we hope to encourage an ecosystem that will accelerate the adoption of precision medicine in healthcare systems, making it equitable by ensuring under-represented populations a represent in genomics databases, especially across Asia Pacific and Japan.

Learn how innovative companies are advancing genomics in consumer & healthcare genomics.

If you require any further information, please contact Illumina Marketing on southapac@illumina.com.

Speakers:

A big data approach to microbiome-based therapeutics and diagnostics
Alena Pribyl - Senior Scientist and Research Officer, Microba (Australia)

 

Development of clinical application of Polygenic Risk Score for Coronary Artery Disease
Giordano Botta - CEO, Allelica (Italy)

 

Unravelling the African Genome with Biobank Driven Research
Dr. Jumi Popoola - Senior Director, Molecular Genetics and Operations, 54gene (Nigeria)

 

Molecular age epigenetics and integrated genomics in wellness
Olaf Schneider - CEO, CeraScreen (Germany)

Date & Time
3 Dec. 2020
Location
Online/Virtual
Asia
Topic
Consumer Genomics
This event has passed
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see sapac.illumina.com/company/legal.html.

© 2024 Illumina, Inc. All rights reserved.